InMed Pharmaceuticals Balance Sheet (2019-2026)

Reported Financials

InMed Pharmaceuticals Quarterly Balance Sheet

Periods 28 quarters

Latest Jun 2026

InMed Pharmaceuticals reported total assets of $3.03M and total liabilities of $1.96M for the quarter ended Jun 2026, down 80.6% year over year. This balance sheet covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	15.34M	11.30M	5.90M	6.18M	9.35M	11.50M	9.60M	8.91M	6.74M	9.53M	7.60M	6.57M	5.58M	3.42M	4.68M	10.74M	9.33M	6.95M	5.16M	2.19M
Short-term InvestmentsInvestments (Current)	15.39M	11.33M	5.94M	0.04M	9.39M	11.50M	9.65M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M
Cash & Current Investments	30.73M	22.63M	11.84M	6.22M	18.74M	23.00M	19.25M	8.96M	6.80M	9.50M	7.60M	6.60M	5.60M	3.50M	4.70M	11.10M	9.40M	7.00M	5.20M	2.20M
Receivables - NetNet Receivables	0.01M	0.05M	0.07M	0.02M	0.02M	0.08M	0.17M	0.07M	0.17M	0.37M	0.21M	0.03M	0.28M	0.26M	0.37M	0.47M	0.34M	0.18M
Receivables	0.01M	0.05M	0.07M	0.02M	0.02M	0.08M	0.17M	0.07M	0.17M	0.37M	0.21M	0.03M	0.28M	0.26M	0.37M	0.47M	0.34M	0.18M
Raw Materials				0.29M		0.21M	0.39M	0.21M	0.21M		0.20M	0.37M	0.27M	0.17M	0.26M	0.26M	0.17M
Work In Process				1.72M		0.80M	0.55M	0.51M	0.09M	0.19M	0.44M	0.03M	0.02M	0.26M	0.32M	0.03M	0.42M	0.57M
Finished Goods				0.47M		0.61M	0.39M	0.89M	0.84M	0.56M	0.56M	0.84M	0.93M	0.68M	0.23M	0.68M	0.30M	0.38M
Inventory		0.99M	1.42M	2.49M	1.78M	1.61M	1.33M	1.62M	1.13M	0.74M	1.19M	1.24M	1.22M	1.10M	0.81M	0.96M	0.89M	0.95M
Prepaid Assets	0.32M	0.14M	1.31M	0.80M	0.36M	0.83M	0.70M	0.50M	0.22M	1.11M	1.02M	0.48M	0.15M	0.64M	0.51M	0.32M	0.19M	0.66M	0.62M	0.24M
Current Assets	15.98M	12.51M	8.75M	9.60M	11.54M	14.02M	11.84M	11.33M	8.30M	11.81M	10.06M	8.69M	7.28M	5.47M	6.41M	12.87M	10.80M	8.79M	6.89M	2.68M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.30M	1.10M	1.00M	0.90M	0.80M	0.70M	0.75M	0.72M	0.62M	1.48M	1.37M	1.25M	1.34M	1.23M	1.11M	0.99M	0.88M	0.76M	0.64M	0.22M
Goodwill		2.02M	2.02M	2.11M				1.95M
Intangibles	1.04M	2.40M	2.36M	2.11M	2.07M	2.03M	1.99M	1.95M	1.91M	1.86M	1.82M	1.78M	1.74M	1.70M	1.66M	1.62M	1.58M	1.54M	1.50M
Goodwill & Intangibles	1.04M	4.42M	4.38M	4.22M	2.07M	2.03M	1.99M	3.89M	1.91M	1.86M	1.82M	1.78M	1.74M	1.70M	1.66M	1.62M	1.58M	1.54M	1.50M
Other Non-Current Assets	0.01M	0.11M	0.11M	0.18M	0.17M	0.17M	0.15M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.13M
Non-Current Assets	1.35M	6.88M	6.74M	3.19M	3.04M	2.90M	2.89M	2.77M	2.62M	3.45M	3.29M	3.13M	3.19M	3.03M	2.87M	2.71M	2.56M	2.40M	2.25M	0.35M
Assets	17.33M	19.38M	15.49M	12.79M	14.58M	16.92M	14.73M	14.11M	10.92M	15.26M	13.36M	11.82M	10.47M	8.50M	9.28M	15.58M	13.36M	11.19M	9.13M	3.03M
Liabilities
Current Liabilities
Accounts Payables	1.92M	3.36M	2.87M	2.42M	2.36M	1.97M	1.83M	1.61M	1.05M	1.29M	1.18M	1.65M	1.01M	1.37M	1.41M	1.23M	1.13M	1.07M	1.01M	1.84M
Notes Payables		0.06M	0.03M
Payables	1.92M	3.42M	2.90M	2.42M	2.36M	1.97M	1.83M	1.61M	1.05M	1.29M	1.18M	1.65M	1.01M	1.37M	1.41M	1.23M	1.13M	1.07M	1.01M	1.84M
Accumulated Expenses	0.14M	0.38M	0.12M	0.27M				0.36M		0.10M	0.17M	0.26M	0.09M
Other Accumulated Expenses				3.18M	3.28M	2.40M	2.27M	0.54M			0.21M	0.49M	0.24M
Current Deferred Revenue		0.01M	0.01M		0.02M	0.02M	0.02M
Total Current Liabilities	1.93M	4.62M	4.11M	3.32M	3.28M	2.40M	2.27M	2.00M	1.34M	1.68M	1.53M	1.97M	1.44M	1.79M	1.84M	1.84M	1.55M	1.48M	2.21M	1.96M
Non-Current Liabilities
Operating Leases	0.18M	0.60M	0.49M	0.39M	0.29M	0.18M	0.07M	0.02M		0.80M	0.73M	0.64M	0.63M	0.53M	0.42M	0.31M	0.22M	0.12M	0.03M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities	2.11M	5.22M	4.60M	3.71M	3.58M	2.58M	2.34M	2.02M	20.50M	2.48M	2.25M	2.62M	2.07M	2.32M	2.26M	2.15M	1.77M	1.60M	2.24M	1.96M
Shareholder's Equity
Total Debt		0.06M	0.03M
Common Equity	15.22M	14.17M	10.89M	9.08M	11.01M	14.34M	12.39M	12.09M	-9.58M	12.77M	11.10M	9.21M	8.40M	6.18M	7.02M	13.43M	11.59M	9.59M	6.89M	1.08M
Liabilities and Shareholders Equity	17.33M	19.38M	15.49M	12.79M	14.58M	16.92M	14.73M	14.11M	10.92M	15.26M	13.36M	11.82M	10.47M	8.50M	9.28M	15.58M	13.36M	11.19M	9.13M	3.03M
Retained Earnings	-77.82M	-82.11M	85.60M	-93.45M	97.00M	99.10M	101.10M	-101.40M	-103.94M	-105.42M	-107.14M	-109.08M	-110.80M	-113.33M	-115.45M	-117.24M	-119.00M	-121.00M	-124.00M	-130.23M

InMed Pharmaceuticals Balance Sheet API

Pull InMed Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INM&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "INM", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=INM&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

InMed Pharmaceuticals INM Balance Sheet (2019-2026)

InMed Pharmaceuticals Quarterly Balance Sheet

InMed Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password